Week 17, 2021

  ECDC COVID-19 landing page    

Key figures on the vaccine rollout in the EU/EEA as of week 17, 2021 (2 May 2021)

Total doses distributed and administered

Total number of vaccine doses distributed by manufacturers to EU/EEA countries: 187 490 581 (29 countries reporting)

Median number of vaccine doses distributed by manufacturers to EU/EEA countries per hundred inhabitants: 49.2 (range: 20.8–98.7) (29 countries reporting)

Total number of vaccine doses administered: 153 770 592 (30 countries reporting)

Cumulative vaccine uptake in adults

Cumulative uptake of at least one vaccine dose among adults aged 18 years and above: median of 30% (range: 10.6–50.5%) (30 countries reporting)

Cumulative uptake of full vaccination among adults aged 18 years and above: median of 11.6% (range: 2.5–25.8%) (30 countries reporting)

Cumulative vaccine uptake in target groups

Cumulative uptake of at least one vaccine dose among persons aged 80 years and above: median of 78% (range: 10.1–100%) (24 countries reporting)

Cumulative uptake of full vaccination among persons aged 80 years and above: median of 56.1% (range: 2.4–97.8%) (24 countries reporting)

Cumulative uptake of at least one vaccine dose among healthcare workers: median of 80.2% (range: 20.4–100%) (16 countries reporting)

Cumulative uptake of full vaccination among healthcare workers: median of 53.7% (range: 17.2–100%) (16 countries reporting)

Cumulative uptake of at least one vaccine dose among residents of long-term care facilities: median of 77.3% (range: 33.6–100%) (11 countries reporting)

Cumulative uptake of full vaccination among residents of long-term care facilities: median of 65.2% (range: 20.5–100%) (11 countries reporting)

For the list of countries reporting data for each indicator, see section 5

1 Introduction

1.1 Purpose and scope

This report provides an overview of the progress in the rollout of COVID-19 vaccines in adults (aged 18 years and above) across EU/EEA countries. It presents: 1) the number of vaccine doses distributed by manufacturers to each country for the different vaccines products authorised for use in the EU; 2) the uptake of at least one vaccine dose, and of full vaccination (regardless of the dosing schedule) in adults - overall, by age group and by other selected target groups (including healthcare workers [HCW] and residents in long-term care facilities [LTCF]). Full vaccination is defined according to the instructions of the manufacturer for each vaccine product. Population denominators for total population and age-specific population are obtained from Eurostat.

The data presented in this report are collected through The European Surveillance System (TESSy). EU/EEA countries are requested to report basic indicators (number of vaccine doses distributed by manufacturers, and number of first, second and unspecified doses administered, by vaccine product) and data by target groups at national level twice a week (every Tuesday and Thursday). For vaccine products that have a one dose vaccination course, the first dose will be the only one administered. Considering this reporting timeframe and the time ECDC needs to process the data, some discrepancies may be observed between the figures published by ECDC and the ones presented in official national reports or websites. Data are subject to retrospective corrections; corrected datasets are released as soon as processing of updated national data has been completed.

While countries are asked to report data by detailed age groups, some may report in a simplified way (<60 and 60 years and above). Data are shown for each age group in this report. The estimated uptake among healthcare workers and residents in long-term care facilities is presented for those countries reporting a denominator for these target groups. Data shown within tables and figures are cumulative except where time-series are shown.

This report complements the interactive ECDC COVID-19 Vaccine Tracker.

1.2 Navigation

Please use the floating table of contents and tabs to navigate between sections and sub-sections. Figures will expand when clicked upon and reduce to normal size when clicked upon again. The report should not be viewed in Internet Explorer as it may not display all features correctly.

1.3 Legal notice and disclaimer

A list of country-specific data disclaimers can be found in the ‘Country disclaimers’ section of the ECDC COVID-19 Vaccine Tracker.

ECDC’s legal notice and disclaimer can be found at https://www.ecdc.europa.eu/en/legal-notice

Users are advised to interpret all data with caution and be aware of their limitations.

These results from the initial phase of the rollout of national campaigns in the EU/EEA should be interpreted with great caution, and comparisons across countries are not advisable at this stage. For their correct interpretation, all possible factors affecting vaccine deployment in each country should be considered, as well as data completeness and quality. Data are subject to retrospective corrections.

Factors that should be taken into account when interpreting these data include the strategic approach of the first phase of the campaign, including priority groups and adaptation of vaccine policies (e.g. delivering the first dose to the highest possible number of individuals vs. ensuring availability of complete course of two doses for two dose schedule vaccines), the vaccination start date, vaccination policies and dosing guidelines (e.g. on timing of second dose and use of additional doses from each vial), challenges in the logistics of deployment of the campaign and vaccine acceptance at the population level, among others.

Possible inconsistencies between the number of doses distributed to countries by the manufacturers and doses administered by vaccine products may be explained by one or more of the following: information on vaccine doses distributed and administered come from different sources at the national level with different reporting timeline; health providers obtain additional doses from each vial of certain vaccine products; data completeness.

2 Vaccine doses distributed and administered

2.1 Doses distributed by manufacturers to EU/EEA countries

2.1.1 Number of vaccine doses distributed by manufacturers to EU/EEA countries

Number of vaccine doses distributed by manufacturers to EU/EEA countries

This graph shows the total number of doses that have been distributed by manufacturers to each EU/EEA country as of 2 May 2021.

2.1.2 Vaccine doses distributed by manufacturers to EU/EEA countries per hundred inhabitants

Vaccine doses distributed by manufacturers to EU/EEA countries per hundred inhabitants

This graph shows the total number of doses that have been distributed by manufacturers to each EU/EEA country as of 2 May 2021 per hundred inhabitants aged 18 years and above.

2.1.3 Map of vaccine doses distributed by manufacturers to EU/EEA countries per hundred inhabitants

Map of vaccine doses distributed by manufacturers to EU/EEA countries per hundred inhabitants

The map shows the total number of doses that have been distributed by manufacturers to each EU/EEA country as of 2 May 2021 per hundred inhabitants aged 18 years and above.

2.2 Trends in vaccine dose distribution by manufacturers to EU/EEA countries

Cumulative weekly number of vaccine doses distributed by manufacturers to EU/EEA countries per hundred inhabitants

This graph shows the cumulative weekly number of vaccine doses distributed by manufacturers to EU/EEA countries as a rate per hundred inhabitants aged 18 years and above as of 2 May 2021.

2.3 Doses distributed by the manufacturers to EU/EEA countries by vaccine product

Vaccine doses distributed by the manufacturers to EU/EEA countries by product

This figure shows the proportion of vaccines distributed by manufacturers to EU/EEA countries by product as of 2 May 2021.

2.4 Doses administered in EU/EEA countries

2.4.1 Number of vaccine doses administered in EU/EEA countries

Number of vaccine doses administered in EU/EEA countries

This graph shows the total number of doses (first dose, second dose and unspecified dose) that have been administered in EU/EEA countries as of 2 May 2021.

2.4.2 Number of vaccine doses administered in EU/EEA countries per hundred inhabitants

Number of vaccine doses administered in EU/EEA countries per hundred inhabitants

This graph show the total number of doses (first dose, second dose and unspecified dose) that have been administered in EU/EEA countries as of 2 May 2021 per hundred inhabitants aged 18 years and above.

2.5 Doses administered out of total distributed to EU/EEA countries

Proportion of vaccine doses distributed to the EU/EEA countries that have been administered (%)

This graph shows the proportion of vaccine doses distributed to EU/EEA countries by the manufacturers that have been administered as of 2 May 2021. It reflects the utilisation of the available stock of vaccine doses in each country.

3 Uptake of at least one vaccine dose among adults

3.1 Uptake of at least one vaccine dose among adults in EU/EEA countries

3.1.1 Uptake of at least one dose among adults aged 18 years and above (%) in EU/EEA countries

Uptake of at least one dose among adults aged 18 years and above (%) in EU/EEA countries

This graph shows an estimate of the uptake for at least one vaccine dose, regardless of the dosing schedule, among adults aged 18 years and above in EU/EEA countries as of 2 May 2021. Vaccine uptake is expressed as a percentage and calculated as the total number of first doses administered divided by the total number of individuals aged 18 years and above in the country.

3.1.2 Map of national uptake of at least one dose among adults aged 18 years and above (%) in EU/EEA countries

Map of national uptake of at least one dose among adults aged 18 years and above (%) in EU/EEA countries

This map shows an estimate of the uptake for at least one vaccine dose, regardless of the dosing schedule, among adults aged 18 years and above in EU/EEA countries as of 2 May 2021 . Uptake is expressed as a percentage and calculated as the total number of first doses administered divided by the total number of individuals aged 18 years and above in the country.

3.2 Cumulative weekly uptake of at least one vaccine dose among adults aged 18 years and above in EU/EEA countries

Cumulative weekly uptake of at least one vaccine dose among adults aged 18 years and above in EU/EEA countries

This graph shows the cumulative weekly uptake of at least one vaccine dose among adults aged 18 years and above in EU/EEA countries each week as a percentage over the country population (18 years or above) as of 2 May 2021. Uptake is expressed as a percentage and calculated as the total number of first doses administered divided by the total number of individuals aged 18 years and above in the country.

3.3 Uptake of at least one vaccine dose among adults by age group in EU/EEA countries

3.3.1 Uptake of at least one vaccine dose among adults aged 18 years and above by detailed age group (%) in EU/EEA countries

Uptake of at least one vaccine dose among adults aged 18 years and above by detailed age group (%) in EU/EEA countries

This graph shows the uptake of at least one dose by age group as of 2 May 2021. This is calculated from the number of first doses administered by age group (18-24, 25-49, 50-59, 60-69, 70-79 and 80+ years) divided by the country population for the specific age group and displayed as a percentage. Uptake is expressed as a percentage and calculated as the total number of first doses administered in individuals by age group divided by the total number of individuals in each age group in the country.

3.3.2 Uptake of at least one vaccine dose among adults aged 18 years and above by age group <60 and 60+ (%) in EU/EEA countries

Uptake of at least one vaccine dose among adults aged 18 years and above by age group <60 and 60+ (%) in EU/EEA countries

This graph shows the uptake of at least one dose by age group as of 2 May 2021. This is calculated from the number of first doses administered by age group (<60 and 60+) divided by the country population for the specific age group and displayed as a percentage.

3.3.3 Uptake of at least one vaccine dose among adults aged 80+ (%) in EU/EEA countries

Uptake of at least one vaccine dose among adults aged 80+ (%) in EU/EEA countries

This graph shows the uptake of at least one dose in persons aged 80 years and above (80+) as of 2 May 2021. This is calculated from the number of first doses administered in persons 80+ divided by the country population for the specific age group and displayed as a percentage.

3.4 Number of doses administered as first vaccine dose among adults by age group in EU/EEA countries

3.4.1 Number of doses administered as first vaccine dose among adults aged 18 years and above by detailed age group in EU/EEA countries

Number of doses administered as first vaccine dose among adults aged 18 years and above by detailed age group in EU/EEA countries

This graph shows the number of first doses administered by age group (18-24, 25-49, 50-59, 60-69, 70-79 and 80+ years) as of 2 May 2021.

3.4.2 Number of doses administered as first vaccine dose among adults aged 18 years and above by age group <60 and 60+ in EU/EEA countries

Number of doses administered as first vaccine dose among adults aged 18 years and above by age group <60 and 60+ in EU/EEA countries

This graph shows the number of first doses administered among adults aged 18 years and above by age group (<60 and 60+ years) as of 2 May 2021.

3.5 Uptake of at least one vaccine dose among healthcare workers

3.5.1 Number of doses administered as first vaccine dose to healthcare workers

Number of doses administered as first vaccine dose to healthcare workers

This graph shows the number of first vaccine doses administered to healthcare workers (HCW) in EU/EEA countries as of 2 May 2021.

3.5.2 Uptake of at least one vaccine dose among healthcare workers

Uptake of at least one vaccine dose among healthcare workers

This graph shows the uptake of at least one dose among healthcare workers (HCW) in EU/EEA countries as of 2 May 2021.

3.6 Uptake of at least one vaccine dose among residents in long-term care facilities

3.6.1 Number of doses administered as first vaccine dose among residents in long-term care facilities

Number of doses administered as first vaccine dose among residents in long-term care facilities

This graph shows the number of doses administered as first vaccine dose to residents in long-term care facilities (LTCF) in EU/EEA countries as of 2 May 2021.

3.6.2 Uptake of at least one vaccine dose among residents in long-term care facilities

Uptake of at least one vaccine dose in long-term care facilities (LTCF)

This graph shows the uptake of at least one vaccine dose in long-term care facilities (LTCF) in EU/EEA countries as of 2 May 2021.

4 Full vaccination uptake among adults

4.1 Full vaccination uptake among adults in EU/EEA countries

4.1.1 Full vaccination uptake among adults in EU/EEA countries

Full vaccination uptake among adults in EU/EEA countries

This graph shows the cumulative number of full vaccinations among adults (aged 18 years and above) in EU/EEA countries as a percentage over the country population aged 18 years and above as of 2 May 2021. Full vaccination is defined according to the instructions of the manufacturer for each vaccine product.

4.1.2 Map of full vaccination uptake among adults in EU/EEA countries

This map shows the cumulative number of full vaccinations among adults (aged 18 years and above) in EU/EEA countries as a percentage over the country population aged 18 years and above as of 2 May 2021 . Full vaccination is defined according to the instructions of the manufacturer for each vaccine product.

4.2 Trends in full vaccination uptake in EU/EEA countries among adults

Cumulative weekly uptake of full vaccination among adults in EU/EEA countries per hundred inhabitants

This graph shows the cumulative number of full vaccinations among adults (aged 18 years and above) in EU/EEA countries each week as a percentage over the country population aged 18 years and above as of 2 May 2021. Full vaccination is defined according to the instructions of the manufacturer for each vaccine product.

4.3 Full vaccination uptake by age group

4.3.1 Full vaccination uptake by age group (%) in EU/EEA countries

Full vaccination uptake by age group (%) in EU/EEA countries

This graph shows the uptake of full vaccination by age group as of 2 May 2021. This is calculated from the number of full vaccinations among adults by age group (18-24, 25-49, 50-59, 60-69, 70-79 and 80+ years) in EU/EEA countries divided by the country population for the specific age group and displayed as a percentage. Full vaccination is defined according to the instructions of the manufacturer for each vaccine product.

4.3.2 Full vaccination uptake by age group <60 and 60+ (%) in EU/EEA countries

Full vaccination uptake by age group <60 and 60+ (%) in EU/EEA countries

This graph shows the uptake of full vaccination by age group as of 2 May 2021. This is calculated from the number of full vaccinations among adults by age group (<60 and 60+) in EU/EEA countries divided by the country population for the specific age group and displayed as a percentage. Full vaccination is defined according to the instructions of the manufacturer for each vaccine product.

4.3.3 Full vaccination uptake among adults aged 80+ (%) in EU/EEA countries

Full vaccination uptake among adults aged 80+ (%) in EU/EEA countries

This graph shows the uptake of full vaccination by age group as of 2 May 2021. This is calculated from the number of full vaccinations among adults by age group (80+) in EU/EEA countries divided by the country population for the specific age group and displayed as a percentage. Full vaccination is defined according to the instructions of the manufacturer for each vaccine product.

4.4 Number of full vaccinations among adults by age group

4.4.1 Number of full vaccinations among adults by age group in EU/EEA countries

Number of full vaccinations among adults by age group in EU/EEA countries

This graph shows the number of full vaccinations among adults by age group (18-24, 25-49, 50-59, 60-69, 70-79 and 80+ years) in EU/EEA countries as of 2 May 2021. Full vaccination is defined according to the instructions of the manufacturer for each vaccine product.

4.4.2 Number of full vaccinations among adults by age group <60 and 60+ in EU/EEA countries

Number of full vaccinations among adults by age group <60 and 60+ in EU/EEA countries

This graph shows the number full vaccinations among adults by age group (<60 and 60+ years) in EU/EEA countries as of 2 May 2021. Full vaccination is defined according to the instructions of the manufacturer for each vaccine product.

4.5 Full vaccination in healthcare workers

4.5.1 Number of full vaccinations in healthcare workers

Number of full vaccinations in healthcare workers

This graph shows the number of full vaccinations among HCW in EU/EEA countries as of 2 May 2021. Full vaccination is defined according to the instructions of the manufacturer for each vaccine product.

4.5.2 Uptake of full vaccination among healthcare workers

Uptake of full vaccination among healthcare workers

This graph shows the uptake of full vaccination among HCW in EU/EEA countries as of 2 May 2021 displayed as a percentage. Full vaccination is defined according to the instructions of the manufacturer for each vaccine product.

4.6 Full vaccination in long-term care facilities

4.6.1 Number of full vaccinations in residents in long-term care facilities

Number of full vaccinations in residents in long-term care facilities

This graph shows the number of full vaccinations among residents of LTCF in EU/EEA countries as of 2 May 2021. Full vaccination is defined according to the instructions of the manufacturer for each vaccine product.

4.6.2 Uptake of full vaccination among residents in long-term care facilities

Uptake of full vaccination among residents in long-term care facilities

This graph shows the uptake of full vaccination among residents of LTCF in EU/EEA countries as of 2 May 2021displayed as a percentage. Full vaccination is defined according to the instructions of the manufacturer for each vaccine product.

5 Data completeness

5.1 EU/EEA countries reporting COVID-19 vaccination data by week

Data as of as of 2 May 2021.

5.2 Reporting completeness for COVID-19 vaccination data by target group (age, healthcare workers and residents in long-term care facilities) and week.

Data as of as of 2 May 2021.

6 Reported data

The table below shows data reported at national level. The variables include: total doses received, number of first doses administered, number of second doses administered and number of administered doses classified as ‘unspecified’.

7 National References

7.1 National COVID-19 vaccine deployment plans

7.2 National data on vaccine rollout

8 Notes on the data

8.1 Specific data quality issues

Austria: Information on vaccine doses administered to healthcare workers and residents in long-term care facilities not currently available. National vaccination register data suggest that vaccination facilities use additional doses in all products, leading to a slightly higher rate of administered doses than doses distributed.

Belgium: The number of doses administered may be greater than the number of doses distributed to the country as there is a one week reporting delay of the number of doses ditributed. Information on doses administered to healthcare workers available up to week 9 (first doses) and week 12 (second doses). Doses administered include individuals aged below 18 years. Denominators for healthcare workers and residents in long-term care facilities not currently available.

Croatia: Denominator for residents in long-term care facilities not currently available.

Cyprus: Vaccine doses administered by age groups are reported only for persons aged 80 years and above (since week 2, 2021) and for persons aged 60 years and above (since week 7, 2021). Denominators for healthcare workers and residents in long-term care facilities not currently available.

Denmark: The number of doses administered may be greater than the total number of doses distributed to the country since vaccinators may obtain more doses than the expected number from each vial. Denominators for LTCF and HCW uptake estimates are adjusted every week.

Estonia: The COVID-19 vaccine uptake in the national dashboard and reports is estimated using population data from Statistic Estonia, while ECDC uses EUROSTAT population data. This may explain possible differences between ECDC and national uptake figures.

Finland: Information on vaccine doses administered to healthcare workers and residents in long-term care facilities not currently available.

France: The data on LTCF is provided until week 15. The indicator for vaccination in LTCF residents is currently under revision.

Germany: Information on vaccine doses administered to healthcare workers and residents in long-term care facilities not currently available. No age-specific data available.

Greece: Information on vaccine doses administered to residents in long-term care facilities not currently available.

Hungary: Vaccine uptake among healthcare workers may exceed 100% since, on an emergency basis, a continuously increasing number of individuals are being enrolled into the healthcare workforce to tackle the COVID-19 epidemic (e.g. medical students), whereas the denominator data reflects the official number of healthcare workers in the country.

Iceland: The number of doses administered may be greater than the number of doses distributed to the country due to usage of more doses per vial when possible.

Ireland: The number of doses administered may be greater than the  number of doses distributed to the country due to possible difference in the timing of availability of information on supplies delivered for the current week. Denominator data for HCW reflects the official number of healthcare workers in the country and underestimate the total number of persons enrolled as a HCW in the COVID-19 vaccination campaign.

Italy: The number of doses administered may be greater than the number of doses distributed to the country due to possible difference in the timing of availability of information on supplies delivered. Denominators for healthcare workers and residents in long-term care facilities not currently available.

Latvia: Denominators for residents in long-term care facilities not currently available.

Liechtenstein: The number of doses administered may be greater than the total number of doses distributed to the country since vaccinators may obtain more doses than the expected number from each vial. Some cumulative data have been reported in week 6 and week 9 to week 11, 2021. Information on vaccine doses administered to healthcare workers and residents in long-term care facilities not currently available. Data disaggregated by age groups not available.

Lithuania: Information on vaccine doses administered to healthcare workers and residents in long-term care facilities not currently available.

Malta: Data on doses of vaccines distributed to the country not provided. Denominators for healthcare workers and residents in long-term care facilities not currently available.

Netherlands: Information on vaccine doses administered to healthcare workers, residents in long-term care facilities and by age groups not currently available. The data reported include the doses for the Caribbean part of the Kingdom of the Netherlands (Dutch Caribbean CAS-BES islands). Currently we only receive both anonymous and non-anonymous vaccination data from the Municipal Health Services. The doses administered by other organizations are therefore estimated based on doses of vaccines that have been distributed to these vaccination locations within the country. In the upload of 28 April an overestimation in the estimated number of vaccinations that occurred in the period 13 April until 27 April as a result of an error in the computer script used was corrected.  This overestimation amounts to about 220,000 vaccine doses. The data reported are estimates based on logistics data and stratification by age and target group is not possible. For more information see: https://www.rivm.nl/covid-19-vaccinatie/cijfers-vaccinatieprogramma

Norway: Data on vaccine doses by vaccine product available from week 13, 2021. The number of doses administered may be greater than the total number of doses distributed to the country since vaccinators may obtain more doses than the expected number from each vial. Information on vaccine doses administered to residents in long-term care facilities currently not available. Denominator for healthcare workers currently not available.

Poland: Denominators for healthcare workers and information on doses administered to residents in long-term care facilities not currently available.

Portugal: Information on vaccine doses administered to healthcare workers and residents in long-term care facilities is not currently available. Vaccines administered in the region of Azores are reported cumulatively in week 10, 2021 and weekly after that.

Romania: Vaccinations distributed by manufacturers to the country and doses administered until week 4, 2021 are reported cumulatively in week 4. Denominator for residents in long-term care facilities not currently available. Data on vaccine doses disaggregated by detailed age groups not available.

Slovakia: Information on vaccine doses administered to healthcare workers and residents in long-term care facilities not currently available. Data on vaccine doses administered to persons aged 80 years and above not currently available.

Slovenia: Information on vaccine doses administered to residents in long-term care facilities not currently available.

Spain: Data on vaccine doses disaggregated by detailed age groups not available.

Sweden: Information on vaccine doses administered to residents in long-term care facilities not currently available.